Muh‐Hwa Yang
- Reproductive Medicine top 5%
- Obstetrics and Gynecology top 5%
- Oncology top 5%
- Cancer Cells and Metastasis 6
- Cancer Immunotherapy and Biomarkers 4
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 14
-
- Lung Cancer Treatments and Mutations 6
- Gastric Cancer Management and Outcomes 4
-
- RNA modifications and cancer 4
-
- Salivary Gland Tumors Diagnosis and Treatment 4
- Co-authors
- Tsai‐Tsen LiaoShih‐Hwa ChiouWei‐Lun HwangYuan‐Tzu LanHao‐Wei TengHsei–Wei WangHsin‐Yi LanShung‐Haur Yang
- Partner nations
- TaiwanUnited StatesThailand
In The Last Decade
Muh‐Hwa Yang
55 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 99
- Reproductive Medicine 196
- Obstetrics and Gynecology 158
- Oncology 456
- Cancer Research 245
- Otorhinolaryngology 63
Countries citing papers authored by Muh‐Hwa Yang
This map shows the geographic impact of Muh‐Hwa Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muh‐Hwa Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muh‐Hwa Yang more than expected).
Fields of papers citing papers by Muh‐Hwa Yang
This network shows the impact of papers produced by Muh‐Hwa Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muh‐Hwa Yang. The network helps show where Muh‐Hwa Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Muh‐Hwa Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 30 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 8 | |
| 9 | 2016 | 1 | |
| 10 | 2016 | 15 | |
| 11 | 2016 | 19 | |
| 12 | 2015 | 13 | |
| 13 | 2013 | 34 | |
| 14 | 2012 | 90 | |
| 15 | 2012 | 11 | |
| 16 | 2011 | 255 | |
| 17 | 2011 | 9 | |
| 18 | 2011 | 4 | |
| 19 | 2010 | 201 | |
| 20 | 2009 | 25 |
About Muh‐Hwa Yang
Muh‐Hwa Yang is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (14 papers), Cancer Cells and Metastasis (6 papers), Lung Cancer Treatments and Mutations (6 papers), MicroRNA in disease regulation (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), RNA modifications and cancer (4 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). The work is most often cited by research in Reproductive Medicine (196 citations), Obstetrics and Gynecology (158 citations) and Oncology (456 citations). Muh‐Hwa Yang has collaborated with scholars based in Taiwan, United States and Thailand. Frequent co-authors include Tsai‐Tsen Liao, Shih‐Hwa Chiou, Wei‐Lun Hwang, Yuan‐Tzu Lan, Hao‐Wei Teng, Hsei–Wei Wang, Hsin‐Yi Lan, Shung‐Haur Yang, Shih‐Ching Chang and Kuan‐Chong Chao. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.